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INTRODUCTION
Severe sepsis and septic shock are complex systemic responses 
to infection and have immunologic, cardiovascular, and pul-
monary implications. There have been numerous treatment 
strategies aimed at reversing pathophysiologic derangement in 
sepsis patients. Since its introduction in a landmark trial in 
2001,1 goal-directed therapy (GDT) has demonstrated signifi-
cant survival benefits in sepsis. GDT focuses on the early initia-
tion of monitoring measurements such as central venous pres-
sure and lactate levels, as well as therapeutic maneuvers 
involving fluid, vasopressors, and transfusion. It was thus a rea-
sonable decision to adopt early GDT in the Surviving Sepsis 
Campaign (SSC) international guidelines due to the accumula-
tion of clinical evidence of its benefits.2,3
However, this method of treating patients with sepsis has 
been challenged by several recent multicenter trials. The ARISE 
trial4 randomized 1600 early septic-shock patients divided into 
GDT and usual-care groups. The investigators found that there 
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was no significant difference in 90-day mortality, duration of 
organ support, and length of hospital stay. Another multicenter 
trial comparing GDT to standard care was the ProCESS study,5 
which showed no differences in 90-day and 1-year all-cause 
mortality or in the need for organ support; this outcome was 
similar to that of the ARISE trial.
To evaluate the effect of GDT on mortality risk reduction, two 
meta-analyses were recently published.6,7
One advocated for the survival benefit of GDT,6 while the 
other showed conflicting results with no difference observed in 
survival; in fact, an even worse outcome was associated with 
GDT in the early-lactate clearance subgroup of patients.7
Given such inconsistent results, we conducted a meta-analy-
sis that included the most recent trials of GDT in patients with 
sepsis. In particular, we assessed the time-dependent changes 
in risk reduction of GDT by performing a cumulative meta-
analysis.
MATERIALS AND METHODS
Ethics committee approval and patient informed consent were 
not required, as we conducted a meta-analysis of previously 
published studies. We followed the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) guide-
lines8 and the Cochrane Handbook of Systematic Review of In-
terventions to perform the study.
Literature search
Two authors (Lee and Kim) independently conducted searches 
in PubMed, Embase, and the Cochrane Register of Controlled 
Trials databases during the period between the March 20, 2015 
and the May 30, 2015 to identify all randomized clinical trials 
involving GDT in human subjects with septic shock. Search 
terms were “sepsis,” “shock,” “septic,” “early goal-directed thera-
py,” “EGDT,” “central venous oxygen saturation,” and “goal-di-
rected resuscitation.” Studies published from January 1992 to 
May 2015 were additionally included.
We also screened the references included in the articles and 
published systematic reviews during the same periods to iden-
tify other potentially eligible studies.
Inclusion criteria
We included prospective clinical trials conducted in adult pa-
tient populations with septic shock. Adults were defined as be-
ing over 17 years of age. The intervention was required to com-
prise GDT, defined as an explicit protocol encompassing the 
use of hemodynamic monitoring as well as manipulation of 
hemodynamic parameters to achieve predetermined hemody-
namic endpoints. The goals regarding the hemodynamic pa-
rameters were different depending on the trials. We defined 
GDT as a treatment with a specific hemodynamic goal. We only 
included studies reporting mortality and excluded those re-
porting only physiological endpoints. Only English-language 
publications were reviewed.
Quality assessment
The quality of the included studies was determined by two in-
dependent assessors who had no role in the design, conduct, 
analysis, or reporting of any of the included studies. The Co-
chrane Collaboration tool was used to assess the risk of bias for 
the randomized studies across the following domains: random 
sequence generation (selection bias), allocation concealment 
(selection bias), blinding of participants and personnel (perfor-
mance bias), blinding of outcome assessment (detection bias), 
incomplete outcome data (attrition bias), selective reporting 
(reporting bias), and other sources of bias.
The RoBANS Tool 9 was used to assess the risk of bias for the 
observational, non-randomized studies across the following 
domains: selection of participants (selection bias), confound-
ing variables (selection bias), measurement of intervention 
(performance bias), blinding for outcome assessment (detec-
tion bias), incomplete outcome (attrition bias), and selective 
outcome reporting (reporting bias). 
Outcome measures
The primary outcome was overall mortality. If the study report-
ed mortality at one time-point, we used only the data provided 
in the study for our analysis. If the study authors reported mor-
tality at more than one time-point, we preferentially used hos-
pital mortality data. Overall mortality was the only measure we 
used to compare the efficacy of GDT.
Fig. 1. Flow diagram showing results of search and reasons for exclusion 
of studies.
PubMed 1475 Embase 3142 Cochrane library 76
1259 records 
were screened
44 articles assessed 
for eligibility
24 studies included 
for meta-analysis
1863 duplicates 
were excluded
1215 records were excluded
· Only abstract
· Non clinical trials
· Not in adults
· Ongoing study
· Not all sepsis patients
20 full text articles were excluded
· Review and meta-analysis 6
· Chinese only 5
· Inappropriate age 4
· Restrospective study 5
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Statistical analysis
Whether heterogeneity between study effects was significant or 
not was evaluated by using the Q statistical value obtained via 
chi-squared distribution analysis in order to identify appropri-
ate studies. The random effect model was adopted where the p-
value of the Q statistic for the accumulated effects was greater 
than 0.1.9 The odds ratio (OR) along with the 95% confidence 
interval (CI) of the overall mortality are presented. Publication 
bias was investigated by using a funnel plot and Egger and 
Begg’s statistical tests.10,11 The funnel plots did not indicate pub-
lication biases, a finding that was further confirmed in the Egg-
er and Begg’s tests, which yielded p-values greater than 0.05. All 
data analyses were performed using Comprehensive Meta-
Analysis version 2.0 (Biostat, Inc., Englewood, NJ, USA).
RESULTS
Identification of eligible trials
In the initial search, we identified 4693 articles (Fig. 1). After the 
removal of 1863 duplicates, we reviewed 1259 titles and ab-
stracts and eliminated 1215 articles not meeting the study in-
clusion criteria. Two investigators reviewed 44 full-text articles 
and subsequently excluded 20 that did not meet the inclusion 
criteria: six articles were reviews or meta-analyses, five were 
published in Chinese only, four were inappropriate owing to 
the age range of those studied (i.e., children or geriatric pa-
tients), and five were retrospective studies. Randomized con-
trolled trials (RCTs), prospective cohort studies, and before-
and-after studies were included in the analysis.
Characteristics of included trials
Twenty-four studies fulfilled the inclusion criteria: 12 each of 
RCTs and non-RCTs. In Table 1, the characteristics of the includ-
ed trials are summarized. The regions where the studies were 
performed included the United States, Canada, Spain, Italy, Ger-
many, Taiwan, Africa, and Australia; thus, there was a broad in-
ternational distribution. The population age targeted by Jones, et 
al.12 was over 17 years, while that targeted by Hayes, et al.13 was 
over 21 years. The protocols for GDT were variable. The early 
studies13-17 targeted the oxygen delivery index, cardiac index, and 
oxygen consumption. The therapeutic targets of the study by Riv-
ers, et al.1 included SvO2 (mixed venous oxygen saturation) >70, 
central venous pressure 8–12, and mean arterial pressure >65. 
The later studies mostly followed the GDT protocol of Rivers, et 
al.,1 and one of the studies modified the protocol by using lactate 
instead of SvO2.18 The target time for therapy administration was 
generally within 6 hours except in five studies; four3,13,15,16 had un-
clear target times and one14 targeted 24 hours. The years of publi-
cation of these studies were between 1992 and 2015.
Risks of bias in the included studies
The details of the risks of bias, summarized in Fig. 2, are each 
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categorized into RCTs and non-RCTs. The RCTs (Fig. 2A) most-
ly exhibited a low risk of bias,4,5,13,14,16,17,19-22 although the risk in 
two studies was unclear.15 Adequate randomized sequences 
were generated in six trials, while proper randomization was 
questionable in two studies. None of the RCTs were double-
blinded; blinding of patients and clinicians is extremely diffi-
cult when treating for septic shock, especially when applying 
GDT protocols. However, we concluded that the primary out-
come (mortality) was seldom influenced by blinding the study. 
Biases related to reporting were low; other biases were unclear.
Almost all non-RCTs (Fig. 2B) were at high risk of selection 
bias except in four studies.12,19,23,24 These four studies were con-
ducted consecutively, and their data were collected prospec-
tively. All non-RCTs were at a high risk of containing con-
founding variables. Four non-RCTs were before-and-after 
investigations,19,23,25 while the others were prospective observa-
tional studies. We assumed that the learning effects were clear 
to the researchers when performing the before-and-after stud-
ies using the GDT protocol. In the prospective observational 
studies, major confounders were confirmed, although adjust-
ing for the confounders was difficult. The bias in measure-
ments was relatively low as the primary outcome was patient 
mortality.
Overall mortality
A total of 13269 patients were available for the analysis of our 
primary endpoint. Overall mortality in the GDT and control 
groups was 1717 of 5259 patients and 1638 of 4655 patients, re-
Ra
nd
om
 se
qu
en
ce
 g
en
er
at
io
n 
(se
le
ct
io
n 
bi
as
)
Se
le
ct
io
n 
of
 p
ar
tic
ip
an
ts
Co
nf
ou
nd
in
g 
va
ria
bl
es
M
ea
su
re
m
en
t o
f i
nt
er
ve
nt
io
n
Bl
in
di
ng
 fo
r o
ut
co
m
e 
as
se
ss
m
en
t
In
co
m
pl
et
e 
ou
tc
om
e 
da
ta
Se
le
ct
ive
 o
ut
co
m
e 
re
po
rti
ng
ProMISe22
ProCESS5
AriSe4
Jones, et al.18
Andrews, et al.21
Lin, et al.29
Rivers, et al.1
Alía, et al.17
Gattinoni, et al.16
Hayes, et al.13
Yu, et al.15
Tuchschmidt, et al.14 Gao, et al.25
Micek, et al.19
Nguyen, et al.26
Jones, et al.12
Zambon, et al.2
Ferrer, et al.23
MacRedmond, et al.24
Puskarich, et al.27
Crowe, et al.30
 De Miguel-Yanes, et al.28
Castellanos-Ortega, et al.3
Coba, et al.20
Al
lo
ca
tio
n 
co
nc
ea
lm
en
t (
se
le
ct
io
n 
bi
as
)
Bl
in
di
ng
 o
f p
ar
tic
ip
an
ts
 a
nd
 p
er
so
nn
el
 (p
er
fo
rm
an
ce
 b
ia
s)
Bl
in
di
ng
 o
f o
ut
co
m
e 
as
se
ss
m
en
t (
de
te
ct
io
n 
bi
as
)
In
co
m
pl
et
e 
ou
tc
om
e 
da
ta
 (a
ttr
iti
on
 b
ia
s)
Se
le
ct
ive
 re
po
rti
ng
 (r
ep
or
tin
g 
bi
as
)
Ot
he
r b
ia
s
A B
Fig. 2. (A) Risk of bias summary of RCTs with Cochrane Collaboration tool. (B) Risk of bias summary of non-RCTs with Cochrane Collaboration tool. RCTs, 
randomized controlled trials.
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spectively. Overall, GDT significantly reduced overall mortality 
in the random-effects model (OR, 0.746; 95% CI, 0.631–0.883; p-
value for heterogeneity <0.0001; I2=57.71%) (Fig. 3). The results 
of the subgroup analyses are presented in Table 2.
RCT-only meta-analysis
In the subgroup analysis (Table 2), we evaluated RCT studies 
only.1,4,5,13-18,21,22,29 GDT had no benefit regarding overall mortality 
compared to the results of all studies including non-RCTs (OR, 
0.929; 95% CI, 0.747–1.155; p-value for heterogeneity=0.024; 
I2=50.07%) (Fig. 4). This result contrasted with that of the analy-
sis of all studies.
Cumulative statistics 
We indexed the studies based on when each was performed 
and then categorized them into three groups: 2001–2003,19,25,29 
2004–2007,2,3,12,18-20,23,25,27-30 and 2008 or later.4,5,21,22,24 This classifi-
cation was according to the SSC publication update. We then 
conducted a cumulative meta-analysis. The results revealed that 
the effectiveness of each GDT was decreasing (Fig. 5) and was 
Model Study name Statistics for each study Odds ratio and 95% CI
Odds 
ratio
0.1 0.2 0.5 1 2 5 10
Lower 
limit
Upper 
limit
Tuchschmidt, et al.14 0.389 0.122 1.245
Yu, et al.15  0.410 0.100 1.681
Hayes, et al.13  1.631 0.681 3.909
Gattinoni, et al.16 1.135 0.586 2.200
Alía, et al.17  1.506 0.508 4.461
Rivers, et al.1  0.518 0.311 0.863
Gao, et al.25  0.313 0.133 0.734
Micek, et al.19  0.576 0.276 1.198
Lin, et al.29  0.461 0.265 0.802
Nguyen, et al.26  0.401 0.219 0.735
Jones, et al.12  0.614 0.286 1.318
Zambon, et al.2  0.270 0.077 0.952
Ferrer, et al.23  0.833 0.702 0.988
MacRedmond, et al.24 0.351 0.133 0.926
Puskarich, et al.27 0.612 0.363 1.034
Crowe, et al.30  0.758 0.477 1.205
De Miguel-Yanes, et al.28 0.750 0.285 1.972
Castellanos-Ortega, et al.3 0.447 0.284 0.704
Jones, et al.18  1.466 0.825 2.604
Coba, et al.20  1.018 0.600 1.728
Andrews, et al.21 1.158 0.533 2.517
ARiSe4  0.988 0.768 1.271
ProCESS5  1.141 0.821 1.584
ProMISe22  1.017 0.796 1.298
  0.822 0.751 0.901
  0.746 0.631 0.883
Fixed
Random
Fig. 3. Forest plot of the effectiveness of goal-directed therapy on overall mortality including RCTs and non-RCTs. RCTs, randomized controlled trials; CI, 
confidence interval.
Table 2. Subgroups Based on Study Type and Initiation Year
Subgroups No. of studies No. of patients OR (95% CI) p value I2 (%)
All trials 24 13269 0.75 (0.63–0.88) <0.0001 57.71
Study type
RCTs 12 6521 0.93 (0.75–1.16) 0.024 50.07
Non-RCTs 12 6748 0.60 (0.48–0.76) 0.031 48.13
Initiation of enrollment
2001–2003 3 817 0.66 (0.44–0.98) 0.041 53.31
2004–2007 11 4472 0.69 (0.55–0.88) 0.003 51.88
2008–2015 5 3921 1.01 (0.87–1.17) 0.899 23.63
RCTs, randomized controlled trials; OR, odds ratio; CI, confidence interval.
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comparable with the subgroup analysis based on the study initi-
ation year (Fig. 6).
Subgroup analysis based on the year of enrollment
In the subgroup analysis (Table 2), we evaluated the initiation 
year of the study enrollment and grouped studies into three pe-
Model Study name Statistics for each study Odds ratio and 95% CI
Odds 
ratio
0.1 0.2 0.5 1 2 5 10
Lower 
limit
Upper 
limit Z-value p-value
ProMISe22 1.017 0.796 1.298 0.132 0.895
ProCESS5 1.141 0.821 1.584 0.785 0.432
ARiSe4 0.988 0.768 1.271 -0.097 0.922
Andrews, et al.21 1.158 0.533 2.517 0.370 0.711
Jones, et al.18 1.466 0.825 2.604 1.303 0.193
Lin, et al.29 0.461 0.265 0.802 -2.743 0.006
Rivers, et al.1 0.518 0.311 0.863 -2.529 0.011
Alía, et al.17 1.506 0.508 4.461 0.739 0.460
Gattinoni, et al.16 1.135 0.586 2.200 0.376 0.707
Hayes, et al.13 1.631 0.681 3.909 1.098 0.272
Yu, et al.15 0.410 0.100 1.681 -1.238 0.216
Tuchschmidt, et al.14 0.389 0.122 1.245 -1.591 0.112
 0.963 0.846 1.097 -0.568 0.570
 0.929 0.747 1.155 -0.663 0.507
Fixed
Random
Fig. 4. Forest plot of the effectiveness of goal-directed therapy on overall mortality including only RCTs. RCTs, randomized controlled trials; CI, confi-
dence interval.
Model Study name Cumulative statistics Cumulative odds ratio (95% CI)
Point
0.1 0.2 0.5 1 2 5 10
Lower 
limit
Upper 
limit
Lin, et al.29 0.461 0.265 0.802
Nguyen, et al.26 0.433 0.288 0.651
Gao, et al.25 0.407 0.282 0.589
Micek, et al.19 0.437 0.314 0.607
Jones, et al.12 0.461 0.340 0.623
Zambon, et al.2 0.448 0.334 0.600
Puskarich, et al.27 0.482 0.373 0.623
Castellanos-Ortega, et al.3 0.474 0.379 0.592
Ferrer, et al.23 0.527 0.397 0.699
Coba, et al.20 0.568 0.437 0.739
Crowe, et al.30 0.592 0.469 0.748
De Miguel-Yanes, et al.28 0.601 0.482 0.750
Jones, et al.18 0.639 0.508 0.804
MacRedmond, et al.24 0.623 0.496 0.782
ARiSe4 0.658 0.533 0.813
ProCESS5 0.692 0.565 0.848
ProMISe22 0.722 0.599 0.870
Andrews, et al.21 0.736 0.614 0.882
 0.736 0.614 0.882Random
Fig. 5. Cumulative forest plot of RCTs and non-RCTs published after 2001. RCTs, randomized controlled trials; CI, confidence interval.
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riods; period 1, before 2003; period 2, 2004–2007; and period 3, 
2008–2015. This categorization was to analyze the change of 
clinical performance with time passage, and the results showed 
that the ORs approached values of 1 as time progressed (period 
1, 0.661; period 2, 0.693; period 3, 1.010). We surmised that the 
difference between the effectiveness of GDT and usual care has 
decreased since 2001, simultaneously with the introduction of 
EGDT. Table 3 shows the amount of fluid administration within 
the first 6 hours in the recent RCTs. In the most recent study, 
the amount of fluid administration was not statistically different 
between the two groups, GDT and usual care.
Publication bias
We detected no evidence of publication bias as determined by 
the funnel plot both visually (Fig. 7) and statistically (p=0.359 by 
the Begg’s test); we also checked the RCTs alone (p=0.837 using 
Begg’s test) (Fig. 8).
DISCUSSION
In this meta-analysis, 12 RCTs and 12 non-RCTs were analyzed 
to compare overall mortality between GDT and non-GDT strat-
egies. GDT remains an effective treatment modality for reduc-
ing the mortality rate among septic shock patients. Prospective 
and retrospective studies accumulated over the years verify the 
efficacy of the GDT protocol in reducing mortality among pa-
tients in septic shock. However, the differences in outcome be-
tween GDT and standard care have been decreasing according 
to recent trials.
A concrete form of GDT focusing on early therapeutic mea-
sures involving fluid, vasopressors, and transfusion to meet pre-
Fig. 6. Subgroup analysis, forest plot by study initiation year (period 1, before 2003; period 2, 2004–2007; period 3, 2008–2015). CI, confidence interval.
Study name Subgroup Statistics for each study Odds ratio and 95% CI
0.1 0.2 0.5 1 2 5 10
Lower 
limit
Upper 
limit
Odds
ratio
Tuchschmidt, et al.14 Period 1 0.389 0.122 1.245
Yu, et al.15 Period 1 0.410 0.100 1.681
Hayes, et al.13 Period 1 1.631 0.681 3.909
Gattinoni, et al.16 Period 1 1.135 0.586 2.200
Alía, et al.17 Period 1 1.506 0.508 4.461
Rivers, et al.1 Period 1 0.518 0.311 0.863
Lin, et al.29 Period 1 0.461 0.265 0.802
Nguyen, et al.26 Period 1 0.401 0.219 0.735
 Fixed 0.620 0.481 0.799
 Random 0.661 0.444 0.983
Gao, et al.25 Period 2 0.313 0.133 0.734
Micek, et al.19 Period 2 0.576 0.276 1.198
Jones, et al.12 Period 2 0.614 0.286 1.318
Zambon, et al.2 Period 2 0.270 0.077 0.952
Ferrer, et al.23 Period 2 0.833 0.702 0.988
Puskarich, et al.27 Period 2 0.612 0.363 1.034
Crowe, et al.30 Period 2 0.758 0.477 1.205
De Miguel-Yanes, et al.28 Period 2 0.750 0.285 1.972
Castellanos-Ortega, et al.3 Period 2 0.447 0.284 0.704
Jones, et al.18 Period 2 1.466 0.825 2.604
Coba, et al.20 Period 2 1.018 0.600 1.728
 Fixed 0.761 0.669 0.865
 Random 0.693 0.546 0.879
MacRedmond, et al.24 Period 3 0.351 0.133 0.926
Andrews, et al.21 Period 3 1.158 0.533 2.517
ARiSe4 Period 3 0.988 0.768 1.271
ProCESS5 Period 3 1.141 0.821 1.584
PreMISe22 Period 3 1.017 0.796 1.298
 Fixed 1.010 0.869 1.173
 Random 1.003 0.833 1.208
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specified targets was introduced by a highly influential single-
center trial performed by Rivers et al.,1 although its primitive 
resuscitation protocol had been attempted beforehand.13-17 
They administered approximately 5 liters of fluid in the first 6 
hours of resuscitation, resulting in a 16% improvement of in-
hospital survival in severe sepsis and septic shock patients.
Although the efficacy of GDT remains a matter of debate, it 
has been rapidly integrated into clinical practice as a form of 
the sepsis bundle due to its definite survival benefit, and its clin-
ical efficacy was established via subsequent trials.27 In recent 
years, it has become less apparent whether GDT has any ad-
vantage for survival of patients with severe sepsis.4,5,22 Investiga-
tors who published the latest meta-analyses, including RCTs, 
have already pronounced the end of the GDT era. However, 
further research is required to identify the efficacy of GDT for 
resuscitation of patients with sepsis and to re-evaluate the ef-
fect of GDT in clinical practice.
In our study, GDT showed no additional efficacy when ana-
lyzing RCTs only. However, in the overall analysis of prospective 
studies, including observational studies, GDT is effective in re-
ducing mortality in sepsis patients. This finding is striking, as 
heterogeneous results from RCTs and observational studies 
could be the reason for detecting inconsistent effects of GDT in 
sepsis patients. The most recent meta-analysis of RCTs failed to 
show a survival benefit with GDT,7 although GDT effectively re-
duced mortality in sepsis patients according to the meta-analy-
sis published prior to the recent large multicenter trials.6
There are several possible explanations as to why the clinical 
benefit of GDT is diminishing in the more recent trials. As we 
observed in the present analysis, the amount of fluid adminis-
tration (Table 3) between standard-care and GDT groups in the 
most recent RCT5 (study period: 2011–2014) was not signifi-
cantly different, compared with other two prior RCTs (Table 3). 
Since GDT was integrated into the SSC guidelines, it has been 
widely adopted as a part of sepsis care, and healthcare profes-
sionals involved in the recent trials were very familiar with GDT 
practices. We surmise that this is why the amount of fluid was 
not different between the standard-care and GDT groups with 
the passage of time.
We also noted the issue of the time of study enrollment, which 
is the reason why we conducted a cumulative meta-analysis to 
assess the time-dependent changes in risk reduction of GDT in 
sepsis patients. Subgroup analysis according to the actual peri-
od of the trial enrollment was performed. There are always time 
intervals between the year of enrollment and study publication; 
a clinical trial of patients with septic shock is extensive and can 
span many years. The actual clinical practices in the field are al-
ways changing; therefore, methods in more recent publications 
will differ from those of previous years. We assumed that the 
GDT protocol set in the year of the initiation of the trial reflected 
the skill and methodology trends of the clinical staff in that par-
ticular year. Hence, in addition to our main analysis, we ar-
ranged the trials chronologically according to the year of initia-
tion of study enrollment and performed a cumulative analysis 
(Fig. 5), which showed that the 95% CIs of the ORs were sur-
passed as more recent trials were included. The comparison of 
the amount of fluid administration in Table 3 also indicates that 
the usual care is changing. The fluid management of usual care 
seems to be becoming similar to the fluid administration of 
GDT. However, we cannot hastily conclude that usual care is 
identical to GDT care based on this data alone.
A limitation of our study was that we included RCTs and non-
RCTs together. We therefore could not dismiss the heterogene-
ity of this study. In Table 2, the overall I2 value was 57.71% for all 
trials, which suggests that there is heterogeneity amongst the 
included trials; therefore, it cannot be ruled out that heteroge-
neity may have affected the results of the analysis. In critical 
care settings, it is extremely difficult to perform randomized 
studies; hence, there are numerous prospective observational 
studies evaluating the effectiveness of GDT.
Table 3. The Amount of Fluid Administration for First 6 Hours, Unit Is 
Presented As mL (Mean±Standard Deviation)
Author (study period) EGDT Control p value
ProCESS (2011–2014)5 2805±1957 2783±1880 0.818
ARiSe (2008–2014)4 1964±1415 1713±1401 0.004*
ProMISe (2008–2013)22 2226±1443 2022±1271 0.001*
EGDT, early goal-directed therapy.
*Statistically significant, p-value<0.05.
Fig. 7. Funnel plot of overall trials, RCTs and non-RCTs (p-value=0.359). 
RCTs, randomized controlled trials.
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Additionally, as we aimed to investigate the effectiveness of 
GDT, the treatment duration goal was heterogeneous. In a sub-
group analysis that includes the initiation of the study enroll-
ment, the year cannot reflect the entire eligibility period of a tri-
al. Even during study enrollment, the clinical performance of 
the medical staff can progress, regress, or change. When ar-
ranging the trials chronologically according to the initiation 
year, such performance changes were not taken into account. 
In summary, this meta-analysis suggests that GDT reduces 
mortality in patients with severe sepsis or septic shock. Howev-
er, a cumulative meta-analysis revealed that the effect of risk re-
duction decreased as more recent studies were incorporated. 
Additional investigation is required prior to making definitive 
recommendations with respect to the effect of GDT on the re-
suscitation of patients with sepsis.
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